Fig. 4From: Liver-specific in vivo base editing of Angptl3 via AAV delivery efficiently lowers blood lipid levels in miceLiver toxicity analysis in mice treated with AAV9-hAAT-Anc/Angptl3. (A, B) Measurement of serum AST and ALT levels in mice at first four weeks after treatment with AAV9-hAAT-Anc/Angptl3. ns, not significant; one-way ANOVA with Turkey’s multiple comparisons testsBack to article page